|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1730 EUR | -1.14% |
|
-7.73% | +1.76% |
| 25-09-30 | Celyad Oncology to Sell Belgian Research Facility for EUR3 Million | MT |
| 25-09-29 | Celyad Oncology announces research facility divestiture | RE |
Quotes 5-day view: Celyad Oncology SA
Real-time Euronext Bruxelles
| 2026-01-09 | 2026-01-12 | 2026-01-13 | 2026-01-14 | Today | |
|---|---|---|---|---|---|
| Last | 0.1895 € | 0.1855 € | 0.1740 € | 0.1750 € | 0.1730 € |
| Volume | 49,388 | 47,298 | 6,642 | 19,554 | 10,569 |
| Change | 0.00% | -2.11% | -6.20% | +0.57% | -1.14% |
| Opening | 0.1800 € | 0.1700 € | 0.1730 € | 0.1800 € | 0.1800 € |
| High | 0.1895 € | 0.1865 € | 0.1855 € | 0.1800 € | 0.1800 € |
| Low | 0.1800 € | 0.1700 € | 0.1730 € | 0.1745 € | 0.1730 € |
Performance
| 1 day | -1.14% | ||
| 1 week | -7.73% | ||
| Current month | +1.76% | ||
| 1 month | -6.49% | ||
| 3 months | -33.20% | ||
| 6 months | -52.08% | ||
| Current year | +1.76% | ||
| 1 year | -67.72% | ||
| 3 years | -78.35% | ||
| 5 years | -97.51% | ||
| 10 years | -99.50% |
Volumes
marketsDaily volume
10,569
Estimated daily volume
10,569
Avg. Volume 20 sessions
28,035
Daily volume ratio
0.38
Avg. Volume 20 sessions
4,850.06
Avg. Volume 20 sessions USD
5,629.7
Record volume 1
1,383,230
Record volume 2
1,230,615
Record volume 3
1,149,340
Capital turnover ratio
0
Float rotation
0
Basic data
Capitalization (EUR)
7,863,458
Capitalization (USD)
9,128,695
Net sales (EUR)
186,000
Net sales (USD)
215,928
Number of employees
18
Sales / Employee (EUR)
10,333
Sales / Employee (USD)
11,996
Free-Float
89.33 %
Free-Float capitalization (EUR)
6,501,074
Free-Float capitalization (USD)
7,547,103
Average Daily Capital Traded
0.06%
Indicators
Moving average 5 days
0.1827
Moving average 20 days
0.1823
Moving average 50 days
0.1898
Moving average 100 days
0.2342
Price spread / (MMA5)
+5.61%
Price spread / (MMA20)
+5.38%
Price spread / (MMA50)
+9.71%
Price spread / (MMA100)
+35.38%
STIM
RSI 9 days
38.77
RSI 14 days
40.92
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.14% | -7.73% | -67.72% | -78.35% | 9.13M | |
| +1.11% | +2.66% | +4.99% | +15.10% | 49.05B | |
| -0.03% | -0.79% | +23.04% | +8.91% | 41.1B | |
| -2.44% | +5.59% | +67.70% | +26.38% | 38.37B | |
| -0.47% | -0.24% | +18.66% | +36.02% | 31.59B | |
| +1.69% | +14.79% | +208.48% | +350.22% | 23.43B | |
| +0.26% | +3.00% | +84.36% | +170.34% | 17.36B | |
| -14.53% | -27.43% | +23,494.98% | +3,950.67% | 17.39B | |
| +0.64% | +5.01% | +57.25% | +12.41% | 14.83B | |
| -1.20% | -3.01% | -8.48% | -19.02% | 14.11B | |
| Average | -1.61% | -2.50% | +2,388.33% | +447.27% | 24.72B | |
| Weighted average by Cap. | -1.09% | -0.54% | +1,698.95% | +335.87% |
Historical Quotes: Celyad Oncology SA
| Date | Opening | High | Low | End-of-day | Volume | Change |
|---|
Latest transactions
7d543d481761d8927bf.8jC_HAi_WoOZD5rsbsOD9Po4c1_9MBFuaQLg_pdaQgs.hFf9RGDQFrr9IveKX5b0l75RQzyZBWYUIkHXt9gYe33LaPwkJY8-0KhO6Q
| Date | Price | Volume | Total |
|---|---|---|---|
| 11:27:02 am | 0.1730 | 397 | 10,459 |
| 11:27:02 am | 0.1740 | 103 | 10,062 |
| 11:16:39 am | 0.1730 | 1,356 | 9,959 |
| 11:16:39 am | 0.1750 | 359 | 8,603 |
| 11:16:39 am | 0.1750 | 1,291 | 8,244 |
| 10:55:42 am | 0.1750 | 50 | 6,953 |
| 05:33:21 am | 0.1785 | 100 | 6,903 |
| 05:06:01 am | 0.1785 | 667 | 6,803 |
| 03:25:13 am | 0.1750 | 75 | 6,136 |
| 03:19:13 am | 0.1750 | 6,000 | 6,061 |
Course Extremes
| 1 week | 0.17 |  | 0.19 |
| 1 month | 0.16 | | 0.19 |
| Current year | 0.17 | | 0.19 |
| 1 year | 0.16 | | 0.96 |
| 3 years | 0.16 | | 2.28 |
| 5 years | 0.16 | | 7.51 |
| 10 years | 0.16 | | 56.48 |
Monthly variations
Annual variations
| 2026 | +1.76% | ||
| 2025 | -76.12% | ||
| 2024 | +82.56% | ||
| 2023 | -22.92% | ||
| 2022 | -85.60% | ||
| 2021 | -46.90% | ||
| 2020 | -31.75% | ||
| 2019 | -41.53% | ||
| 2018 | -52.07% | ||
| 2017 | +94.33% | ||
| 2016 | -63.20% | ||
| 2015 | +42.77% | ||
| 2014 | +32.68% | ||
| 2013 | +53.45% |
- Stock Market
- Equities
- CYAD Stock
- Quotes Celyad Oncology SA
Select your edition
All financial news and data tailored to specific country editions
